Consistent with a previous report that TNFSF13 may be beneficial for the recovery of COVID-19 patients22, we found that TNF superfamily member and its respective receptors were enriched in high-dose group, particularly at day 14 post-vaccination. The gene discussed is TNFSF13; the disease is COVID-19.